Chitosan nanoparticle-delivered siRNA reduces CXCR4 expression and sensitizes breast cancer cells to cisplatin

Chemokine (C-X-C motif) receptor 4 (CXCR4) has been reported as a poor prognostic biomarker in human breast cancers, and has been suggested as a promising therapeutic target of breast cancer treatment. The present study aims to investigate the delivery efficiency of siRNA by chitosan into breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shaonan, Chen, Yan, Li, Xuefeng, Gao, Zhongli, Liu, Guifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434078/
https://www.ncbi.nlm.nih.gov/pubmed/28446538
http://dx.doi.org/10.1042/BSR20170122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434078/
https://www.ncbi.nlm.nih.gov/pubmed/28446538
http://dx.doi.org/10.1042/BSR20170122

Ejemplares similares